May 11, 2018 · 28m · 20vc
20VC: Hims' Andrew Dudum on The Scaling Playbook of The Fastest Growing Mens Wellness Brand, How To Be Truly Innovative In Today's World of Online Marketing & Raising at a $200m Valuation within Year 1
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
In this episode of The 20 Minute VC, host Harry Stebbings speaks with Andrew Dudum, co-founder and CEO of Hims and general partner at Atomic. Dudum shares insights on innovative direct-to-consumer marketing, hyper-lean team execution, validating distribution through venture builder models, and navigating early-stage startup valuations.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. Harry holds 31.6% of the talking time here. How this is scored →
speaking balance: gold is Harry, purple is the guest (3 minute bins)
Andrew firmly rejects Harry's suggestion that a $200M valuation limits exit options, reframing Hims as a high-margin pharmaceutical brand rather than a traditional DTC business.
Hardest push from Harry ▶ 15:32 Challenging the $200M valuation growthHarry directly presses Andrew on whether raising at a $200M valuation within six months of launching over-extends the company and eliminates acquisition options.
Biggest teaching moment ▶ 15:56 Pharma subscription economics re-educationAndrew thoroughly breaks down Hims' recurring prescription revenue and pharmaceutical gross margins, compelling Harry to admit he was thoroughly proven wrong and eating humble pie.
Harry holds his own ▶ 15:32 Probing valuation multiples and exit ceilingsHarry demonstrates keen venture capital acumen by challenging how fast valuation growth impacts future financing rounds and M&A flexibility.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | Harry as informed peer | Guest teaching | Guest disagreement | Harry pushing back | Why |
|---|---|---|---|---|---|---|
| Andrew Dudum on the Founding and Mission of Hims | 1 | 2 | 0 | 0 | Harry sets up friendly introductory questions regarding Hims' founding story and Andrew's prior startup learnings. Andrew explains the market gap in men's health and lessons around micro-optimization from Everalbum without any friction. | |
| Navigating DTC Marketing and Creating Proprietary Inventory | 3 | 4 | 1 | 1 | Harry asks insightful questions about CAC inflation and channel sustainability across DTC brands. Andrew gently reframes Harry's question on migration timing by arguing that if a brand waits for channel fatigue to migrate, it is already too late, advocating instead for proprietary inventory creation. | |
| Real-World Touchpoints and Customer Conversion Science | 4 | 4 | 1 | 2 | Harry displays domain knowledge regarding mattress DTC stats and incumbent dynamics like Gillette versus Harry's, pressing Andrew for exact touchpoint metrics. Andrew declines to share proprietary numbers and re-educates on demographic-specific conversion science, leading Harry to playfully self-deprecate. | |
| Scaling Operations, Hiring Philosophy, and Valuation Considerations | 4 | 7 | 3 | 5 | Harry directly challenges Hims' $200M valuation achieved in under six months, asking if it prices the company out of potential M&A options. Andrew forcefully dismantles this premise by explaining Hims' pharmaceutical-grade margins and subscription retention, forcing Harry to admit he was eating humble pie. | |
| The Atomic Venture Builder Model and Distribution Testing | 3 | 5 | 2 | 2 | Harry asks sharp questions about Atomic's venture builder model and return distributions. Andrew explicitly corrects Harry's assumption that 90% of Atomic projects generate strong returns, clarifying that the vast majority are killed during early distribution testing. | |
| Quickfire Round: Leadership Insights and Future Vision | 1 | 1 | 0 | 0 | A standard, highly collaborative quickfire round covering leadership, book recommendations, and Silicon Valley culture. Neither host nor guest displays combativeness or pushback. |